Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09BYB
|
||||
| Former ID |
DNC010178
|
||||
| Drug Name |
2-(tert-butylamino)-1-p-tolylpropan-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530728] | ||
| Formula |
C14H21NO
|
||||
| Canonical SMILES |
CC1=CC=C(C=C1)C(=O)C(C)NC(C)(C)C
|
||||
| InChI |
1S/C14H21NO/c1-10-6-8-12(9-7-10)13(16)11(2)15-14(3,4)5/h6-9,11,15H,1-5H3
|
||||
| InChIKey |
BMWDQBTXNBGORC-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [530728] | |
| Sodium-dependent dopamine transporter | Target Info | Inhibitor | [530728] | ||
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| WikiPathways | Monoamine Transport | ||||
| NRF2 pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsWP727:Monoamine Transport | |||||
| Dopaminergic Neurogenesis | |||||
| Parkinsons Disease Pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
| Neurotransmitter Clearance In The Synaptic Cleft | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.